Last reviewed · How we verify

NCT03372525

Invasive Ventilation Strategies for Neonates With Acute Respiratory Distress Syndrome Syndrome (ARDS)

Status unknown NA Last updated 14 October 2022
What this trial tests

NA trial testing HFOV in Acute Respiratory Distress Syndrome in 400 participants. Status unknown.

Timeline
1 December 2018
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment400
Start date1 December 2018
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Who can join

Adults 1 Minute to 12 Hours, any sex, with Acute Respiratory Distress Syndrome or Bronchopulmonary Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute respiratory distress syndrome (ARDS) in neonates has been defined in 2017.The death rate is over 50%. HFOV and CMV are two main invasive ventilation strategies. However, which one is better needing to be further elucidated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of HFOV

Trials testing the same drug.

Other recruiting trials for Acute Respiratory Distress Syndrome

Currently open trials in the same condition.

Other Daping Hospital and the Research Institute of Surgery of the Third Military Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03372525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing